New drug for inhibiting aggregation of proteins involved in diseases linked to 
protein aggregation and/or neurodegenerative diseases.

Giese, A.; Bertsch, U.; Kretzschmar, H.; Habeck, M.; Hirschberger, T.; Tavan, P.; Griesinger, C.; Leonov, A.; Ryazanov, S.; Weber, P.

Datensatz

DATENSATZ AKTIONENEXPORT

DownloadE-Mail

Bitte beachten Sie, dass eine neuere Version dieses Datensatzes verfügbar ist:
https://pure.mpg.de/pubman/item/item_1504346_8

DetailsÜbersicht

New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases.

Giese, A., Bertsch, U., Kretzschmar, H., Habeck, M., Hirschberger, T., Tavan, P., et al.(2010). New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-000F-D1F6-C Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0027-D58E-3

Genre: Patent

ausblenden:

Urheber:
Giese, A., Autor
Bertsch, U., Autor
Kretzschmar, H., Autor
Habeck, M., Autor
Hirschberger, T., Autor
Tavan, P., Autor
Griesinger, C.¹, Autor
Leonov, A.¹, Autor
Ryazanov, S.¹, Autor
Weber, P., Autor

Affiliations:
1Department of NMR-Based Structural Biology, MPI for biophysical chemistry, Max Planck Society, ou_578567

Inhalt

einblenden:

ausblenden:

Schlagwörter: -

Zusammenfassung: The present invention relates to a compound represented by formula (E). The present invention also relates to a compound represented by the formula (E) for use in the treatment or prevention of diseases linked to protein aggregation and/or neurodegenerative diseases. Moreover, the present invention relates to pharmaceutical and diagnostic compositions comprising the compound of the invention as well as to a kit. Furthermore, the present invention relates to a method of imaging deposits of aggregated protein. A kit for preparing a detectably labelled compound of the present invention is also disclosed. Formula (E) wherein X, Y and L are independently nondirectionally selected from -C(R1)(R2)-, -C(R3)=, -N(R4)-, -N=, -N+(R5)=, -O- and -S-; M and Z are independently nondirectionally selected from formula (I) and formula (II).